|1.||Reyes, O: 2 articles (10/2004 - 02/2003)|
|2.||Garay, H: 2 articles (10/2004 - 02/2003)|
|3.||Araña, M J: 2 articles (10/2004 - 02/2003)|
|4.||Vallespi, Maribel G: 2 articles (10/2004 - 02/2003)|
|5.||Richter, Walter: 1 article (09/2007)|
|6.||Howe, Jörg: 1 article (09/2007)|
|7.||Brandenburg, Klaus: 1 article (09/2007)|
|8.||Moriyon, Ignacio: 1 article (09/2007)|
|9.||Andrä, Jörg: 1 article (09/2007)|
|10.||Leiva-León, José: 1 article (09/2007)|
10/01/2004 - "Differential regulation of Th1/Th2 in relevant tissues for sepsis pathogenesis with a Limulus anti-LPS factor-derived peptide increases survival in Gram-positive sepsis."
10/01/2004 - "In this study, we examined the effect of a Limulus anti-LPS factor (LALF)-derived peptide on lung and liver Th1/Th2 cytokine mRNA levels during a Gram-positive sepsis. "
|2.||Septic Shock (Toxic Shock Syndrome)
02/01/2003 - "We previously observed that a cyclic peptide derived from the Limulus anti-LPS factor (LALF), which partially protect mice from endotoxic shock lethality, has the ability to modulate cytokine secretion in vitro. "
09/01/2007 - "On the basis of formerly investigated peptides corresponding to the endotoxin-binding domain from LALF [Limulus anti-LPS (lipopolysaccharide) factor], a protein from Limulus polyphemus, we have designed and synthesized peptides of different lengths with the aim of obtaining potential therapeutic agents against septic shock syndrome. "
|4.||Bacterial Infections (Bacterial Infection)
|1.||Messenger RNA (mRNA)